Now accepting new patients · Same-day appointments available
Medical Weight Loss

Ozempic vs Wegovy: What's the Difference? (Same Drug, Explained by a Queens MD)

Confident woman in athletic wear in a calm clinic setting, considering a medical weight loss program
Quick answer

What is the difference between Ozempic and Wegovy?

Ozempic and Wegovy are the same active ingredient — semaglutide, made by Novo Nordisk. The difference is the FDA-approved use and maximum dose: Ozempic is approved for type 2 diabetes (up to 2 mg), while Wegovy is approved for chronic weight management (up to 2.4 mg). The molecule is identical.

Two names, one molecule

Patients ask me this almost every week: "Should I get Ozempic or Wegovy for weight loss?" It's a fair question, because the marketing makes them sound like two different drugs. They are not.

I'm Dr. Keisha Bryant, a board-certified internal medicine physician in St Albans, Queens. Here's the honest, plain-English version: Ozempic and Wegovy are two brand names for the exact same active ingredient — semaglutide. Both are made by the same manufacturer (Novo Nordisk). The molecule injected into your body is identical. What differs is the FDA-approved use, the maximum dose, and the box it comes in.

So why two names? Because the FDA approves medications for specific indications (the condition they're allowed to be marketed for), and a drug company brands the same molecule differently for each approved use.

The actual differences, side by side

OzempicWegovy
Active ingredientSemaglutideSemaglutide
ManufacturerNovo NordiskNovo Nordisk
FDA-approved forType 2 diabetesChronic weight management
Maximum doseUp to 2 mg/weekUp to 2.4 mg/week
How it's takenWeekly injectionWeekly injection
MechanismGLP-1 receptor agonistGLP-1 receptor agonist

That's genuinely the whole list. Same drug, same maker, same weekly injection, same mechanism. The headline differences are what it's approved to treat and how high the dose goes.

Why the FDA approvals differ

This is the part that confuses people, so let me slow down.

  • Ozempic was FDA-approved first, for type 2 diabetes — to lower blood sugar in adults with diabetes. Doctors noticed patients on it also lost meaningful weight.
  • Wegovy is the same semaglutide molecule that Novo Nordisk then studied and got FDA-approved specifically for chronic weight management — for adults with obesity (BMI 30+) or who are overweight (BMI 27+) with a weight-related condition like type 2 diabetes, high blood pressure, or sleep apnea.

So when you hear "Ozempic for weight loss," what's happening is that a diabetes drug is being prescribed off-label for weight. When you hear "Wegovy," that's the version the FDA reviewed and approved for weight management — which is why it's allowed to go to the higher 2.4 mg dose.

The simplest way to remember it: Ozempic is the diabetes label, Wegovy is the weight label — but the medicine inside is semaglutide either way.

Does the difference matter for weight loss?

Honestly? Less than the internet makes you think. The molecule is the same, so the biology is the same. What actually matters for your results:

  • The dose you reach and tolerate. Both work by reducing appetite and "food noise." Higher, well-tolerated doses tend to drive more weight loss — but only if you titrate up slowly and your body handles it.
  • Supervision and follow-up. A medication checked monthly by a physician, with labs and dose adjustments, beats a fixed prescription nobody is watching.
  • The plan around it. Protein, strength training, and sleep are what protect your muscle and make the loss last.

In the STEP clinical-trial program, adults on semaglutide for weight management lost on average roughly 10–15% of body weight over about 12 months. Individual results vary. Those are clinical-trial averages, not a promise of what any one person will lose.

What we actually use: a cash-pay Semaglutide program

At Dr. Bryant Medical, our medical weight-loss program uses Semaglutide — the same active ingredient as Ozempic and Wegovy. We prescribe FDA-approved medication from a licensed U.S. pharmacy — never compounded online or drop-shipped from an unknown source.

Here's why a cash-pay program exists at all: insurance coverage for Ozempic and Wegovy is inconsistent and the brand pens are expensive out of pocket. Many patients either can't get coverage or get stuck in prior-authorization limbo. Our program is built to be straightforward instead:

  • $199/mo (Semaglutide), all-inclusive — covers medication, monthly MD check-in, dose titration, labs, unlimited messaging, and a nutrition plan.
  • Prefer a different molecule? We also offer Tirzepatide — the same active ingredient as Mounjaro/Zepbound — at $250/mo, all-inclusive. That's a different medication, not just a different brand; we compare them in our Semaglutide vs Tirzepatide guide.

Every patient is supervised by Dr. Keisha Bryant, MD — a board-certified physician — with a monthly check-in, gradual dose titration, and lab monitoring. This isn't a fixed prescription you fill and forget.

How we keep side effects manageable

I'd rather you hear this from a doctor than from a forum. The common side effects of semaglutide are mild nausea, indigestion, and constipation — usually showing up during dose increases and typically settling within about a week. To keep them tolerable, Dr. Bryant titrates the dose slowly over 4–8 weeks rather than jumping you to a high dose. Most people who go slowly tolerate it well.

Talk to us first if

Semaglutide isn't right for everyone. Please tell us — and talk to us before starting — if any of these apply to you:

  • You are pregnant or breastfeeding, or planning pregnancy.
  • You have a personal or family history of medullary thyroid cancer, or MEN2 (multiple endocrine neoplasia type 2).
  • You have a history of pancreatitis.
  • You take medications that may interact with a GLP-1, including insulin or other diabetes medicines.

These are exactly the things a physician screens for — and exactly what a telehealth site that never sees your history can't do safely.

Who qualifies?

Semaglutide for weight management is generally appropriate for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as type 2 diabetes, high blood pressure, or sleep apnea. That said, BMI is a screening tool, not a diagnosis — your final eligibility is decided by the MD at your free 15-minute consult, based on your history, labs, and goals.

The bottom line

If you're choosing between "Ozempic and Wegovy" for weight loss, you're really choosing between two brand names for one molecule — semaglutide. What changes your outcome isn't the label on the pen; it's the dose you reach, the supervision around it, and the plan you build. Our program gives you the active ingredient, prescribed and watched by a board-certified MD, at a predictable all-inclusive price.

We're at 205-15 Hollis Avenue, St Albans, NY 11412, phone +1 (718) 217-3744, open Mon–Sat 9–5. If you're in Queens and want a real plan built around your labs and your life, book a free 15-minute consult and we'll figure out together whether semaglutide is right for you.

Note: This article is educational and not medical advice. Medications and weight-loss plans are individualized and prescribed only within a physician-patient relationship. Figures are clinical-trial averages; they are not a guarantee of individual results.

Frequently asked questions

Is Ozempic the same as Wegovy?
Yes — Ozempic and Wegovy are two brand names for the same active ingredient, semaglutide, made by the same manufacturer (Novo Nordisk). The molecule is identical. The differences are the FDA-approved use (Ozempic for type 2 diabetes, Wegovy for chronic weight management) and the maximum dose (2 mg vs 2.4 mg per week).
Why are there two different names for the same drug?
The FDA approves medications for specific uses, and a manufacturer brands the same molecule differently for each approved use. Ozempic is the semaglutide brand approved for type 2 diabetes; Wegovy is the semaglutide brand approved for weight management at a higher maximum dose. Same medicine, two labels.
Which is better for weight loss, Ozempic or Wegovy?
Since both are semaglutide, the biology is the same. Wegovy is the version FDA-approved for weight loss and goes to a slightly higher dose (2.4 mg). For results, the dose you tolerate, MD supervision, and your nutrition and strength plan matter more than the brand. Individual results vary.
How much weight can I expect to lose on semaglutide?
In the STEP clinical-trial program, adults lost on average roughly 10–15% of body weight over about 12 months. These are clinical-trial averages, not a guarantee — individual results vary based on dose tolerated, consistency, and the plan around the medication, all of which Dr. Bryant monitors monthly.
What does Dr. Bryant's Semaglutide program cost?
It's $199/mo for Semaglutide, all-inclusive — covering FDA-approved medication from a licensed U.S. pharmacy, a monthly MD check-in, dose titration, labs, unlimited messaging, and a nutrition plan. Tirzepatide (a different molecule, same active ingredient as Mounjaro/Zepbound) is $250/mo, all-inclusive.
What are the side effects, and who should not take it?
Common side effects are mild nausea, indigestion, and constipation, usually during dose increases and typically resolving within a week; Dr. Bryant titrates slowly over 4–8 weeks. Talk to us first if you're pregnant or breastfeeding, have a personal or family history of medullary thyroid cancer or MEN2, a history of pancreatitis, or take medications that may interact.
Together a healthier you

Ready to talk to a real MD?

Book a free 15-minute consult with Dr. Bryant in St Albans, Queens. Real screening, real conversation, no sales pressure.

Book Free Consult
Call Book free consult